MRIGlobal’s Containerized Bio Containment System, designed and fabricated in just 191 days, is a finalist in R&D Magazine’s R&D 100 Awards
Kansas City, Mo. – MRIGlobal’s state-of-the-art, flight-ready Containerized Biocontainment System (CBCS) has been named a finalist by R&D Magazine for the coveted 2016 R&D 100 Awards.
Effectively addressing global public health challenges, such as Ebola, requires the commitment of medical professionals. A major recruitment challenge has been limited access to medical evacuation should health workers become ill and need access to medical treatment. To help solve this challenge, a $5 million dollar private-public partnership grant between Paul G. Allen and the State Department was established for the development and manufacture of the CBCS.
Designed by MRIGlobal, the CBCS is a reusable bio-containment and medical treatment unit, designed to be operated on government/civilian cargo aircraft. The CBCS are designed to fully contain highly-contagious pathogens. The units are extremely durable and safe, which will allow for the secure transport of healthcare workers abroad. The CBCS can treat four critically ill patients while maintaining biocontainment and safe flight.
“The CBCS was designed to save lives,” said Dean Gray, Ph.D., Director of Special Programs, MRIGlobal. “There’s nothing like this in the world right now and it was developed in response to an urgent need.”
See the video here: https://youtu.be/RI7WcxRSWhA
Considered to be the Oscars of Innovation, each year R&D Magazine presents the awards to 100 of the most innovative technologies and services of the past year. Winners will be presented with their honors at the annual awards dinner on November 3.